$26.48
+0.80 (+3.12%)
At Close: Jul 13, 2026
Denali Therapeutics (NASDAQ:DNLI) Is In A Strong Position To Grow Its Business
04:01pm, Tuesday, 31'st Dec 2019
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Sign In
Buy DNLI